London, UK--(Marketwire - June 14, 2007) -
SKYEPHARMA TO PRESENT AT PIPER JAFFRAY
2nd ANNUAL HEALTH CARE CONFERENCE
LONDON, UK, 14 June 2007-- SkyePharma PLC (LSE: SKP) announces today that the
Company's Chief Operating Officer, Dr Ken Cunningham, will make a presentation
at the Piper Jaffray 2nd Annual Health Care Conference in London. Dr
Cunningham will deliver his presentation on Thursday 21 June 2007 at 2.40 p.m.
Investors may access a live webcast of the presentation at
www.skyepharma.com
under the Investor Relations tab. The presentation will be archived for 3
months.
For further information please contact:
SkyePharma PLC Frank Condella +44 20 7491 1777
Ken Cunningham
Peter Grant
Financial Dynamics (UK Enquiries) David Yates +44 20 7831 3113
Deborah Scott
Trout Group (US Enquiries) Christine Labaree +1 617 583 1308
Seth Lewis
About SkyePharma PLC
Using its proprietary drug delivery technologies, SkyePharma develops new
formulations of known molecules to provide a clinical advantage and life-cycle
extension. The Company has eleven approved products in the areas of oral,
inhalation and topical delivery that are marketed throughout the world by
leading pharmaceutical companies.
For more information, visit
www.skyepharma.com
This information is provided by RNS
The company news service from the London Stock Exchange